Georgia Center for Diabetes Translation Research

A recent review published in JAMA authored by GCDTR’s @JacobsenLM and Desmond A. Schatz highlights key advances in understanding autoimmune mechanisms, early detection, and evolving treatment strategies. pubmed.ncbi.nlm.nih.gov/41697686/

Congratulations to Francisco Pasquel on his appointment as Section Chief of Endocrinology, Metabolism, & Lipids at Emory University Hospital Midtown. A leader across Emory Global Diabetes Research Center & @GCDTR, advancing diabetes care & research.

A recent study co-authored by GCDTR’s Roy W Beck @JaebCenter examines how CGM metrics relate to severe hypoglycemia in type 1 diabetes. Hypoglycemia measures were strongly associated with events, but prediction remained limited. pubmed.ncbi.nlm.nih.gov/41837438/

A recent study coauthored by GCDTR researchers and @JaebCenter studied the impact of inhaling Technosphere insulin for youth with type 1 diabetes. In a multicenter study, inhaled insulin produced smaller post-meal glucose excursions and lower peak glucose. pubmed.ncbi.nlm.nih.gov/41830209/

In case you missed it: Watch the GCDTR Virtual Speaker Series featuring Stefano Del Prato, MD, titled Can type 2 diabetes truly go into remission? as he shared the evidence, clinical realities, and future of diabetes remission. youtu.be/Am_wTRQQm78

In a recent webinar, “The Central Role of Weight Management in the Care of People with Type 2 Diabetes,” by Dr. Juan Frias where he shared how obesity drives T2DM & related complications, why early weight management should be a primary treatment goal. youtu.be/Gr2kOE-ve28

In the recent GCDTR webinar, @ADA_DiabetesPro Roadmap to a World Free from Diabetes, by @ChuckatADA & Dr. Rita Kalyani shared the roadmap, applying research, advocacy, education, & connection to diabetes care, access, nutrition, obesity, & primary care. youtu.be/drWpMbwYrRQ

A recent study coauthored by GCDTR’s Roy W Beck @JaebCenter studied data from 647 technosphere insulin users vs 1,830 controls & found zero lung cancer cases, 0.16% COPD/emphysema/bronchitis vs 1.48% in controls, a reassuring safety profile @UWMedicine pubmed.ncbi.nlm.nih.gov/41566693/

A recent study coauthored by GCDTR’s Roy W Beck @JaebCenter shows Control-IQ+, an automated insulin system,benefits adults with type 2 diabetes across diverse populations. Key findings are 0.9% HbA1c reduction, 14% higher time-in-range. pubmed.ncbi.nlm.nih.gov/41574573/

Join the GCDTR Research Summit on Jan 29, 2026 at11 AM–5 PM at @MSMEDU (Atlanta, GA). Featuring pilot awardee presentations, faculty spotlights, funding insights, and discussions on community & clinical partnerships. Register here: tally.so/r/3lPyWp

A new study coauthored by GCDTR’s @ThaerIdrees found that people with type 1 diabetes are living longer, as clinicians increasingly care for older adults with T1D. Their complex needs differ from T2D, pose diagnostic challenges in older adults. pubmed.ncbi.nlm.nih.gov/41361045/

A new study by GCDTR’s Roy W. Beck @JaebCenter found that continuous glucose monitoring is emerging as a powerful complement (or alternative) to HbA₁c and finger-stick testing for type 2 diabetes. jamanetwork.com/journals/jama/…

A recent Diabetes Care study co-authored by GCDTR’s Roy W. Beck @JaebCenter shows that Automated Insulin Delivery offers significant benefits for many insulin-treated type 2 diabetes patients, including those on current medications and GLP-1 RAs. tinyurl.com/333hmtz7

Join us Dec. 15 at 12PM for a powerful conversation with @AmDiabetesAssn CEO Chuck Henderson and #ADA Chief Scientific & Medical Officer Dr. Rita Kalyani as they share the organization’s strategic roadmap toward a world free from #diabetes. Register: zoom.us/meeting/regist…

In a recent seminar by GCDTR’s Dr. Scott Isaacs shared a comprehensive overview of Metabolic Dysfunction–Associated Steatotic Liver Disease. He discussed the global burden of the disease, the updated diagnostic terminology, & tools for risk stratification youtube.com/watch?v=4UOL8Q…

A recent study, NHALE-1, coauthored by Dr. Kristina Cossen & Roy Beck found - inhaled technosphere insulin (TI) is safe but did not meet noninferiority criterion for HbA1c higher satisfaction & less weight gain vs. rapid-acting analog insulin. tinyurl.com/yc47ea6w

A recent study by GCDTR researchers from @EmoryUniversity shows continuous glucose monitoring detects 5× more hypoglycemia than fingerstick testing. agsjournals.onlinelibrary.wiley.com/doi/10.1111/jg…

Happy Diabetes Awareness Month! This month, we stand with millions around the world in raising awareness, advancing research, and strengthening action against diabetes. #DiabetesPrevention #GlobalHealth #GCDTR

A multicenter randomized clinical trial co-authored by GCDTR’s researchers at @JaebCenter found that 1 year after Descemet membrane endothelial keratoplasty, endothelial cell loss and morphometry were not affected by donor diabetes status. jamanetwork.com/journals/jamao…

A new Jackson Heart Study co-authored by GCDTR’s @DrDaynaAJohnson highlights hypertension as a key factor in CKM syndrome among Black adults. Early blood pressure management could prevent heart, kidney, and metabolic issues. pubmed.ncbi.nlm.nih.gov/41046247/